• Prof. Dr. Deniz Yamac currently works as an Medical Oncologist and Professor at Guven International Hospital, Turkey.
• She is a well educated and qualified doctor who cares for her patients and treats them with respect.
• She has treated countless patients and has experience of more than 25 years in her field.

Specialty

• Breast Cancer
• Head & neck cancer
• All Types of other cancers

Training

• Prof. Dr. Deniz Yamac graduated from the Faculty of Internal Medicine and Medical Sciences at Gazi University in 1991.
• She completed her specialization in Oncology from Faculty Of Medicine, Gazi University, Turkey in 1997.

Publications

• Prof. Dr. Deniz Yamac is great at research and writing. Many of her research articles have been published in national and international journals. She has authored many book chapters too. Have a look at some of her internationally published works below:
• Efficacy and toxicity of preoperative chemotherapy with docetaxel and epirubicin in locally advanced invasive breast cancer. Kaya AO, Coskun U, Buyukberber S, Benekli M, Tekin E, Cifter C, Ozturk B, Yildiz R, Yaman E, Uner A, Yamac D. J BUON. 2010 Apr-Jun;15(2):248-54. 
•  The effect of bevacizumab on serum soluble FAS/FASL and TRAIL and its receptors (DR4 and DR5) in metastatic colorectal cancer. Yildiz R, Benekli M, Buyukberber S, Kaya AO, Ozturk B, Yaman E, Berk V, Coskun U, Yamac D, Sancak B, Uner A. J Cancer Res Clin Oncol. 2010 Oct; 136(10):1471-6. Epub 2010 Feb 13. 
•  Education, economic status and other risk factors in gastric cancer: "a case-control study of Turkish Oncology Group". Icli F, Akbulut H, Yalcin B, Ozdemir F, Isıkdogan A, Hayran M, Unsal D, Coskun S, Buyukcelik A, Yamac D. Med Oncol. 2011 Mar;28(1):112-20. Epub 2010 Jan 7. 
• Bevacizumab plus irinotecan-based therapy in metastatic colorectal cancer patients previously treated with oxaliplatin-based regimens. Yildiz R, Buyukberber S, Uner A, Yamac D, Coskun U, Kaya AO, Ozturk B, Yaman E, Benekli M. Cancer Invest. 2010 Jan;28(1):33-7. 
• Peritumoral lymphatic microvessel density associated with tumor progression and poor prognosis in gastric carcinoma. Coşkun U, Akyürek N, Dursun A, Yamaç D.J Surg Res. 2010 Nov;164(1):110-5 Epub 2009 May 3.

Experience

• Prof. Dr. Deniz Yamac works as an Oncologist and Professor at Guven International Hospital, Turkey. 
• Prof. Deniz served at a cancer center in Arkansas/USA for a year.
• She gained experience as a Faculty member at the Faculty Of Medicine, Gazi University in 1995.
• She was appointed as Professor in Gazi University in 2011.